Skip to main content

Animations

MJFF Publications

3031 - 3040 of 9034 Results
Title
Year
  • Year
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2024
  • 2023
  • 2024
  • 2024
  • 2023
  • Summary Details
    OPEN
    Title: Accuracy of the Early Diagnosis of Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29556
    Citation Count: 4
  • Summary Details
    OPEN
    Title: A Double‐Blind, Randomized, Placebo‐Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29450
    Citation Count: 50
  • Summary Details
    OPEN
    Title: Trajectories of depressive symptoms over 20 years and subsequent lower urinary tract symptoms and impact among women
    Journal Name: Menopause
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1097/gme.0000000000002193
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Basal activity of PINK1 and PRKN in cell models and rodent brain
    Journal Name: Autophagy
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1080/15548627.2023.2286414
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Elevated ApoE, ApoJ and lipoprotein-bound α-synuclein levels in cerebrospinal fluid from Parkinson's disease patients – Validation in the BioFIND cohort
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105765
    Citation Count: 6
  • Summary Details
    OPEN
    Title: The annotation of GBA1 has been concealed by its protein-coding pseudogene GBAP1
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1126/sciadv.adk1296
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Future directions in psychiatric neurosurgery: Proceedings of the 2022 American Society for Stereotactic and Functional Neurosurgery meeting on surgical neuromodulation for psychiatric disorders
    Journal Name: Brain Stimulation
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.brs.2023.05.011
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Exploring the role of underrepresented populations in polygenic risk scores for neurodegenerative disease risk prediction
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2024.1380860
    Citation Count: 8
  • Summary Details
    OPEN
    Title: KAT8 compound inhibition inhibits the initial steps of PINK1-dependant mitophagy
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-024-60602-9
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Patients with progressive supranuclear palsy need to be seen sooner and more frequently
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105883
    Citation Count: 6
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.